AstraZeneca Brazil

  Convenção-Quadro das Nações Unidas sobre a Mudança do Clima (CQNUMC). UN Climate Change Conference - Belém, November 2025. Acesso em: Maio/2025. Disponível em: https://unfccc.int/cop30 Vilela P, et al. WCN24-1271 Social inequality in the prevalence of chronic kidney disease in Brazil. Kidney Int Rep. 2024;9(4):S264–S265. doi:10.1016/j.ekir.2024.02.543.Zoccali C, Barraclough K, Eckelman M, Cases Amenos A, Germond-Duret C, Pecoits-Filho R, et al. THE ENVIRONMENTAL IMPACT OF CHRONIC KIDNEY DISEASE INTERNATIONALLY: RESULTS OF A LIFE CYCLE ASSESSMENT. Nephrol Dial Transplant. 2023 Jun;38(Suppl 1):gfad063c_2695. doi:10.1093/ndt/gfad063c_2695Whaley-Connell A, et al. The importance of early identification of chronic kidney disease. Mo Med. 2011 Jan-Feb;108(1):25–8. PMID: 21462606; PMCID: PMC6188457.Kushner P, et al. Early identification and management of chronic kidney disease: a narrative review of the crucial role of primary care practitioners. Adv Ther. 2024 Oct;41(10):3757-3770. doi: 10.1007/s12325-024-02957-z. Epub 2024 Aug 20. PMID: 39162984; PMCID: PMC11399210.7.Andrade MV, et al. Allocation of initial modality for renal replacement therapy in Brazil. Clin J Am Soc Nephrol. 2010 Sep;5(9):1470–8. doi:10.2215/CJN.00720110Bauer AC, et al. Chronic Kidney Disease in Brazil: Current Status and Recommended Improvements. Kidney Dis (Basel). 2024;10(1):26–34. doi:10.1159/000533710World Health Organization (WHO). Seventy-eighth World Health Assembly – Daily update: 23 May 2025. Acesso em: Maio/2025. Disponível em: https://www.who.int/news/item/23-05-2025-seventy-eighth-world-health-assembly---daily-update--23-may-2025.International Society of Nephrology (ISN). Historic win for kidney health as WHO adopts global resolution. Acesso em: Maio/2025. Disponível em: https://www.theisn.org/blog/2025/05/23/historic-win-for-kidney-health-as-who-adopts-global-resolution/.AstraZeneca. Transforming kidney health and the burden of CKD (Stand: 21. November 2024). Acesso em: Maio/2025. Disponível em: https://www.astrazeneca.com/media-centre/articles/2023/transforming-kidney-health-burden-ckd.html.Jager KJ, Kovesdy C, Langham R, Rosenberg M, Jha V, Zoccali C. A single number for advocacy and communication—worldwide more than 850 million individuals have kidney diseases. Kidney Int. 2019 Nov;96(5):1048–50. Disponível em: https://pubmed.ncbi.nlm.nih.gov/31582227/International Society of Nephrology. Global Kidney Health Atlas: 2023 [Internet]. Brussels: ISN; 2023. Disponível em: https://www.theisn.org/wp-content/uploads/media/ISN%20Atlas_2023%20Digital_REV_2023_10_03.pdfNational Kidney Foundation. Kidney disease: fact sheet. Acesso em: Maio/2025. Disponível em: https://www.kidney.org/news/newsroom/fsindex.Centers for Disease Control and Prevention (CDC). Chronic Kidney Disease: Common - Serious – Costly. Acesso em: Maio/2025. Disponível em: https://www.cdc.gov/kidney-disease/ckd-facts/index.html. Last accessed: May 2025. Centers for Disease Control and Prevention (CDC). Chronic Kidney Disease in the United States, 2023. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention; 2023. Acesso em: Maio/2025. Disponível em: https://www.cdc.gov/kidney-disease/media/pdfs/CKD-Factsheet-H.pdf. Last accessed May 2025. Oliveira C, et al. Cardiovascular Risk Factors in Patients with Chronic Kidney Disease Under Conservative Treatment. Int J Cardiovasc Sci 2020;34(2):170-8.Zoccali C, et al. Cardiovascular complications in chronic kidney disease: a review from the European Renal and Cardiovascular Medicine Working Group of the European Renal Association. Cardiovasc Res. 2023 Sep 5;119(11):2017-2032. doi: 10.1093/cvr/cvad083. PMID: 37249051; PMCID: PMC10478756.James G., et al. Low Adherence to Kidney Disease: Improving Global Outcomes 2012 CKD Clinical Practice Guidelines Despite Clear Evidence of Utility. Kidney Int Rep. 2022;7(9):2059-2070.Tangri N., et al. Patient management and clinical outcomes associated with a recorded diagnosis of Stage 3 chronic kidney disease: the REVEAL-CKD study. Adv Ther. 2023;40(6):2869-2885.Tangri N., et al. Projecting the epidemiological and economic impact of chronic kidney disease using patient-level microsimulation modelling: rationale and methods of INSIDE CKD. Adv Ther. 2022;40(1):265-281.Sanchez J.J.G, et al. PCR153 Pace CKD: The Impact of Chronic Kidney Disease and Dialysis on Caregivers Financial Status, and Work Productivity: Results from a Multinational Survey. Value in Health. 2023;26(12). Supplement: S278.Rao N., et al. Holistic Impact of CKD: A Clinical, Economic, and Environmental Analysis by IMPACT CKD. Kidney Int Rep. 2025:2468-0249.

 

Conteúdo destinado ao público em geral BR- BR-41324

 

 

 

View original content:https://www.prnewswire.com/br/comunicados-para-a-imprensa/diagnostico-precoce-e-tratamento-adequado-podem-evitar-1-6-milhao-de-mortes-por-doenca-renal-cronica-e-reduzir-pela-metade-a-necessidade-de-dialise-no-brasil1--302536678.html

FONTE AstraZeneca